Mutual of America Capital Management LLC Sells 385 Shares of Waters Co. (NYSE:WAT)

Mutual of America Capital Management LLC trimmed its stake in shares of Waters Co. (NYSE:WAT) by 4.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,905 shares of the medical instruments supplier’s stock after selling 385 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Waters were worth $2,603,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Waters by 0.5% during the first quarter. Vanguard Group Inc. now owns 6,689,208 shares of the medical instruments supplier’s stock worth $2,076,263,000 after acquiring an additional 30,274 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Waters by 1.4% in the third quarter. Bank of New York Mellon Corp now owns 3,520,629 shares of the medical instruments supplier’s stock worth $965,392,000 after purchasing an additional 48,740 shares in the last quarter. Alliancebernstein L.P. increased its holdings in Waters by 37.2% in the second quarter. Alliancebernstein L.P. now owns 2,018,487 shares of the medical instruments supplier’s stock worth $538,008,000 after purchasing an additional 547,777 shares in the last quarter. Wellington Management Group LLP increased its holdings in Waters by 79.6% in the first quarter. Wellington Management Group LLP now owns 1,504,592 shares of the medical instruments supplier’s stock worth $467,011,000 after purchasing an additional 666,851 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in shares of Waters by 2.7% during the first quarter. Geode Capital Management LLC now owns 1,229,235 shares of the medical instruments supplier’s stock valued at $379,738,000 after acquiring an additional 32,360 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Up 0.6 %

WAT stock opened at $295.98 on Friday. The stock has a market cap of $17.55 billion, a P/E ratio of 27.28, a P/E/G ratio of 5.85 and a beta of 0.92. The stock’s fifty day simple moving average is $335.88 and its two-hundred day simple moving average is $305.56. The company has a current ratio of 2.22, a quick ratio of 1.57 and a debt-to-equity ratio of 2.00. Waters Co. has a 1-year low of $231.90 and a 1-year high of $363.80.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.56 by $0.06. The firm had revenue of $819.50 million for the quarter, compared to analyst estimates of $815.50 million. Waters had a return on equity of 81.30% and a net margin of 21.72%. The business’s revenue was down 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $3.84 earnings per share. Analysts expect that Waters Co. will post 11.89 EPS for the current year.

Insider Buying and Selling at Waters

In other Waters news, Director Linda Baddour sold 500 shares of the business’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total value of $177,770.00. Following the sale, the director now directly owns 2,250 shares in the company, valued at $799,965. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.98% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on WAT shares. Barclays boosted their price objective on Waters from $275.00 to $300.00 and gave the company an “underweight” rating in a report on Monday, February 12th. Evercore ISI lifted their target price on Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research report on Thursday, April 4th. Finally, Stifel Nicolaus lifted their target price on Waters from $290.00 to $330.00 and gave the company a “hold” rating in a research report on Wednesday, February 7th. One analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $298.67.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.